Spascolon

Quick links to important sections

Spascolon

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Spascolon

Property Description
Active Ingredient Pinaverium bromide
Form Film-coated Oral Tablet
Pharmacological Class Antispasmodic Agent (Spasmolytic)
General Purpose Relieves muscle spasms in the gut
Origin Synthetic (Quaternary ammonium compound)

Spascolon is a prescription-required pharmaceutical preparation known for its sole active ingredient, Pinaverium bromide. Administered orally as a film-coated tablet, it is primarily used for the symptomatic management of functional digestive issues. This formulation establishes Spascolon as a focused, single-ingredient entity for managing discomfort originating from the gastrointestinal system.


What Type of Medicine is Spascolon?

Spascolon is classified pharmacologically as a spasmolytic agent and belongs to the subcategory of gastrointestinal-selective Calcium Channel Blockers (CCB). The active substance, Pinaverium bromide, is a synthetic quaternary ammonium compound that ensures a defined chemical structure and consistent purity in the final preparation. This pharmacological profile makes Spascolon a targeted approach often used when patients experience recurring abdominal pain and cramping associated with conditions like Irritable Bowel Syndrome (IBS).

Pinaverium bromide is an effective option for reducing the symptoms of irritable bowel syndrome.


Why is Spascolon Called a Selective Antispasmodic?

Spascolon is termed selective because its primary action is targeted at the smooth muscles of the digestive tract, modulating the necessary influx of calcium ions (Ca^2+) for muscle contraction in the gut. This focused approach differentiates it from systemic calcium antagonists, which can have broader effects. Pinaverium bromide is a selective and specific voltage-dependent calcium channel blocker located on intestinal smooth muscle cells. This localized action is intended to concentrate its anti-spasmodic effects where they are needed most.

What side effects are possible with Spascolon?

Possible Side Effects and Safety Information

The safety profile for Pinaverium bromide (the active ingredient in Spascolon) is based on classifications published by government regulatory agencies. Adverse reactions are grouped by the affected physiological system, primarily involving Gastrointestinal disorders and Skin and subcutaneous tissue disorders.


Official Adverse Reaction Frequencies

Side effects are categorized according to MedDRA frequency standards in official labeling:

  • Common (occurring in 1 to 10 out of 100 people): Includes abdominal pain, nausea, constipation, dyspepsia (indigestion), and dry mouth.
  • Uncommon (occurring in 1 to 10 out of 1,000 people): Includes diarrhea, vomiting, and asthenia (physical weakness).
  • Frequency Not Known: This category includes reactions reported spontaneously where the exact rate of occurrence cannot be reliably estimated. Examples are hypersensitivity, headache, somnolence, rash, and urticaria (hives).

Documented Serious Reactions and Safety Constraints

The regulatory profile documents the potential for rare but serious adverse reactions, such as Anaphylactic shock and Angioedema. A specific, clinically significant safety constraint involves the upper digestive tract: the potential for Esophageal lesions and ulcers is noted if the tablets are not administered correctly, due to the local irritating nature of the substance.

Regulatory documents also detail limitations regarding specific populations. The medicine is not recommended for use in the pediatric population because safety and efficacy have not been established. Use is also not recommended during pregnancy or lactation due to insufficient data.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Spascolon (Pinaverium bromide) overdose is documented based on the clinical manifestations and the required emergency actions.

Documented Manifestations and Management

Official regulatory sources state that overdose may lead to primary gastrointestinal complaints, specifically listing diarrhea and flatulence as the documented presentations. In human exposure, high daily doses are noted to have induced no undesirable effects beyond these limited gastrointestinal symptoms. Regulatory bodies have also noted that no cases of overdosage have been formally reported in humans to date.

Management of an overdose is constrained by the official statement that no specific antidote is known for Pinaverium bromide. Therefore, if an overdosage is suspected, regulatory authorities recommend immediate symptomatic treatment to address the presenting clinical signs.

Urgent Medical Attention Required

The official guidance mandates that individuals must seek immediate medical attention for any suspected overdosage. Regardless of whether symptoms are present, it is required to contact a health care professional, hospital emergency department, or regional Poison Control Centre immediately. No specific population-based overdose risks or distinct monitoring requirements for the elderly or those with hepatic or renal impairment are explicitly documented in the official labeling.

Therapeutic Uses of Spascolon

What Spascolon Treats: Main Uses and Benefits

Spascolon is applied across therapeutic domains where short-term symptomatic assistance is needed for conditions involving episodic or fluctuating manifestations. The compound is used for managing groups of symptoms that may appear suddenly, most commonly the relief of Irritable Bowel Syndrome (IBS) and certain functional disorders of the biliary tract.

In clinical scenarios where symptoms intensify and supportive relief is needed, Spascolon helps address symptom clusters that interfere with daily functioning. It is relevant for easing distress associated with physical discomfort and heightened physiological activity, such as cramping, abdominal pain, and general intestinal discomfort.

The medicine provides support that helps ease the overall burden of symptoms. “...helps maintain a sense of stability when symptoms become more noticeable.

Quick Fact: Relief for Intestinal Spasms


Symptomatic Domains

Spascolon is commonly used to help with symptom clusters related to the gastrointestinal area, primarily focusing on conditions characterized by periods of heightened muscle activity or tension.

  • Abdominal Spasm and Pain: The medication assists with maintaining functional stability when symptoms create noticeable physiological strain in the digestive tract.
  • Irritable Bowel Syndrome (IBS) Symptoms: It contributes to improved day-to-day comfort by managing recurrent manifestations like bloating, cramping, and associated discomfort.
  • Functional Biliary Tract Disorders: It is applied in situations involving certain distressing symptoms linked to temporary physiological imbalance in this area.

Regulatory References

  1. UK Legislation on Mebeverine Hydrochloride

Eligibility and Restrictions for Use

Official Eligibility Rules for Spascolon

Regulatory documents strictly define the populations eligible to use Spascolon (Pinaverium bromide). Use is generally approved for adults but is restricted or prohibited in several defined groups.

Absolute Contraindications

The medicine is formally contraindicated and must not be used by patients with a known hypersensitivity to the active ingredient or any excipients. This also applies to patients with rare hereditary metabolic disorders such as galactose intolerance or Lapp lactase deficiency.

Age and Life Stage Restrictions

Population Group Regulatory Status
Children & Adolescents (Under 18) Not Recommended (Safety and efficacy not established).
Breastfeeding Women Contraindicated (Risk to the infant cannot be excluded).
Pregnant Women Restricted (Use only if considered essential to the patient’s welfare).

Comorbidity and Condition Restrictions

Spascolon must not be used for digestive motility issues caused by an underlying organic disease (structural pathology). Patients with conditions like a hiatus hernia may use the medicine but must adhere to special administration instructions detailed on the label to prevent local irritation. Efficacy data is not established for patients with severe renal or liver failure.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Pinaverium bromide focuses on documented pharmacodynamic effects, specific administration constraints, and the reported absence of systemic interactions with certain drug classes.


Documented Pharmacodynamic Interactions

Category Official Interaction Statement
Pharmacodynamic Augmentation Co-administration of an anticholinergic drug may result in the enhancement of spasmolysis.
CNS Effects Concurrent use with Alcohol or Cannabis may lead to enhanced central nervous system effects, specifically dizziness or drowsiness.
Absence of Interaction Regulatory trials demonstrated the absence of interaction with digitalis drugs, oral anti-diabetics, insulin, and oral anticoagulants.

Administration-Related Restrictions

The regulatory labeling requires specific administration constraints to prevent a local interaction risk with the esophageal mucosa. The tablet must be swallowed whole with a full glass of water during a meal and must not be chewed or sucked.


Population-Specific Data Gaps

Interaction studies have not been conducted in certain patient populations. Specifically, official regulatory data is unavailable for use in patients with liver failure, renal failure, or the pediatric population.

Mechanism of Action

Selective Ion Channel Blockade and Spasmolysis

Spascolon's mechanism centers on the selective inhibition of L-type voltage-dependent calcium channels (Cav1) found on the smooth muscle cells of the gastrointestinal (GI) tract. By stabilizing these channels in a closed state, the drug blocks the influx of Ca^2+ ions required to initiate and maintain muscle contraction. This action directly produces spasmolysis, which modulates the intensity and frequency of abnormal muscle hypercontractility, contributing to a reduced physiological tone in the intestinal walls.


Dual-Action Visceral Response Modulation

The physiological effect is localized due to the drug's poor systemic absorption. This specificity ensures the mechanism's influence on Ca^2+ channels in systemic tissues (such as the cardiovascular system) remains limited. Additionally, the molecule exerts a secondary effect that desensitizes the sensory nerve endings within the gut wall. This dual modulation (muscle relaxation and sensory input adjustment) acts to constrain the physiological response to internal stimuli and excessive motility.

Dosage and Administration Information

How to Use Spascolon

Spascolon (pinaverium bromide) is a prescription-required medicine administered orally as a film-coated tablet, with dosing structured to manage symptoms through a routine schedule. The typical adult dosage regimen involves divided use, commonly requiring administration three times a day (TID). The standard initial dose is 50 mg per administration, with the option to increase to 100 mg per administration, provided the total daily intake does not exceed the recommended maximum of 300 mg.


Official Administration Technique

Adherence to the specific method of ingestion is a critical aspect of use to ensure proper delivery and minimize the risk of local irritation. The tablet must be taken during a meal or with a snack and swallowed whole. It is strictly prohibited to crush, chew, or suck the tablets. The dose should be swallowed with a full glass of water while the patient is in an upright position, and it is generally advised not to lie down for an extended period, such as 30 minutes, after taking the medication.


Frequency and Population Guidance

The frequency pattern is a structured, divided daily dose, though specific, short-term regimens may be utilized for certain medical preparations, such as a BID (twice daily) schedule for three days before a barium enema. If a dose is missed, general instructions indicate that it should be skipped if it is close to the next scheduled dose; taking a double dose to compensate is not permitted. The medicine is not recommended for use in children due to insufficient data establishing its safety and effectiveness in pediatric populations.

Recent Clinical Evidence

Spascolon: Recent Clinical Evidence

Research Evidence for Irritable Bowel Syndrome (IBS) Symptoms

Spascolon (Pinaverium bromide) was studied for its use in clinical trials, primarily multiple Randomized Controlled Trials (RCTs). These are studies used in research exploring how symptoms change over time and compare the medicine against a control, often a placebo. Research examined outcomes related to the reported intensity and frequency of abdominal pain, and studies explored the change in stool consistency, often using the Bristol Stool Form Scale. Data show patterns related to abdominal pain and overall symptom scores that were observed in the studies, contributing to understanding how symptoms evolved in the observed populations.

Comparing Trial Measurements and Duration of Study

The main studies and systematic reviews compared the reported measurements of patients observed in the Spascolon group against those who received an inactive placebo, as well as against the patient’s initial symptom status. These trials were typically conducted over relatively short-term treatment periods, generally lasting four to twelve weeks.

Crucially, some trials have included extended post-treatment follow-up periods to assess the status of symptoms after the medicine was discontinued. This research explored the Post-Treatment Therapeutic Effect (PTTE), monitoring symptom recurrence for periods that have been reported to extend up to 57 weeks in some specific study designs.

Uncertainty and Research Gaps

The vast majority of the clinical research was studied for use in adult patients with IBS, often those whose condition was classified using specific criteria. Findings describe group patterns, not personal outcomes, and results apply only to the populations studied.

A key research limitation is the methodological heterogeneity across trials. Furthermore, long-term effects are not fully established beyond the post-treatment follow-up periods. There is also a notable gap in evidence and trials for pediatric populations, and comparative evidence against all alternative pharmacological options is a developing area.

Frequently Asked Questions (FAQ)

Common questions about Spascolon (FAQ)

Q: How quickly should I expect to feel the effects of Spascolon?

A: Regulatory information indicates that the medication is poorly absorbed, and the concentration in the bloodstream typically peaks within about one hour after a dose is administered. However, the time it takes to feel the desired clinical outcome is usually not specified in the official documents, as studies often observe symptom changes over several weeks.

Q: What is the longest time a person typically takes Spascolon for?

A: The length of time a person takes Spascolon is determined by prescribing information and individual response. Clinical trials often study the medication over short-term periods, commonly between four and twelve weeks. Official information advises that treatment duration should be determined by clinical needs.

Q: Can children or teenagers take Spascolon?

A: Official product information states that the use of Spascolon is not recommended for children and adolescents under 18 years of age. This is because the safety and effectiveness of the medicine have not been established through clinical research in this specific age group.

Q: Is Spascolon safe for someone with mild liver issues?

A: Official regulatory data on the use of Spascolon is not established for patients who have severe kidney or liver failure, meaning regulatory documents imply caution. Individuals with liver issues should follow the guidance of their prescribing healthcare professional.

Q: Can Spascolon be crushed or chewed, or must it be swallowed whole?

A: According to official administration instructions, the tablets is required to be swallowed whole with a full glass of water during a meal. The tablets should not be crushed, chewed, or sucked. This administration method is necessary because the active substance can be locally irritating if the tablet is damaged.

Q: Can Spascolon be used during breastfeeding?

A: Spascolon is generally contraindicated (not recommended for use) during breastfeeding. This restriction is in place because the possibility of risk to the infant cannot be excluded based on the available regulatory data.

Q: What scientific evidence supports the use of Spascolon for stomach discomfort?

A: Clinical trials have studied Spascolon's effectiveness in managing symptoms related to Irritable Bowel Syndrome (IBS), which is its official indication. Specifically, studies have examined the medication's ability to help manage the frequency and intensity of abdominal pain and other associated digestive discomfort.

Q: How long does the antispasmodic effect of one dose of Spascolon last?

A: The medication is typically administered three times a day to ensure a consistent therapeutic effect. Official data indicates that the mean elimination half-life of the active ingredient, Pinaverium, is approximately 1.5 hours.

Q: What is the difference between Spascolon and other IBS medications?

A: Spascolon is classified as a gastrointestinal-selective Calcium Channel Blocker (CCB) and a spasmolytic agent. It works by acting specifically on the calcium channels of the smooth muscle cells in the gut to prevent muscle spasms. Its mechanism is focused on localized relaxation in the digestive tract.

Q: Are there any known long-term side effects of using Spascolon?

A: The majority of clinical research supporting Spascolon was conducted over short-term treatment periods, typically lasting only a few weeks. Due to this, regulatory labels state that the safety of the medication and any long-term effects beyond the studied follow-up periods are not fully established.

Q: Does Spascolon affect blood pressure?

A: Because the drug is poorly absorbed into the body and acts selectively on the gut, its influence on calcium channels in other systemic tissues, like the cardiovascular system, is considered limited. However, some clinical trial data has reported an increase in blood pressure as an adverse effect in a small number of patients.

Q: Are there foods or drinks I should avoid while using Spascolon?

A: Official regulatory labels require that the medicine is administered during a meal or with a snack. The label also includes a warning that using the medication concurrently with alcohol may lead to enhanced central nervous system effects, such as dizziness or drowsiness.

Q: Are there any reported cases of Spascolon causing weight gain?

A: Weight gain is not listed in the official regulatory profile that categorizes the Common, Uncommon, or Frequency Not Known side effects for the active ingredient, Pinaverium bromide.

Q: How long does Spascolon stay in your system after stopping it?

A: The elimination of the drug is relatively fast. Official pharmacokinetic data shows that the mean elimination half-life of Pinaverium is approximately 1.5 hours.

Q: Why do some people say Spascolon gives them mild headaches?

A: Headache is listed in the official regulatory profile as a possible side effect. It is categorized with a Frequency Not Known, which means that while it has been reported, the exact rate of occurrence cannot be reliably estimated from clinical data.

Q: What makes Spascolon different from a general painkiller for period cramps?

A: Spascolon is classified as a spasmolytic agent, which means its action is focused on directly relaxing the smooth muscles of the gastrointestinal tract to relieve gut spasms. General painkillers, like NSAIDs often used for period cramps, typically work systemically to block pain signals or reduce inflammation.

Q: Is it possible to take too much Spascolon accidentally?

A: The regulatory documents establish a maximum recommended daily dose. Official labels detail information for healthcare professionals regarding the management of an overdose. Exceeding the maximum daily dosage should only be done under the authorization and guidance of a healthcare professional.

Q: Can women who are planning pregnancy take Spascolon?

A: Spascolon is generally restricted during established pregnancy and should only be used if it is considered essential for the patient’s well-being. Regulatory documents do not provide specific guidance for the pre-conception or pregnancy planning stage.

Q: Does research support Spascolon's use in non-diagnosed 'nervous stomach'?

A: Spascolon is officially indicated for the symptomatic treatment of Irritable Bowel Syndrome (IBS) and functional disorders of the biliary tract, which are formal clinical diagnoses. The regulatory information does not specifically address non-diagnosed or lay terms like 'nervous stomach'.

Q: Can Spascolon cause changes in vision?

A: Changes in vision are not listed in the official regulatory categorization of Common, Uncommon, or Frequency Not Known side effects for the active ingredient, Pinaverium bromide.

Q: Are there any mood changes associated with taking Spascolon?

A: Mood changes are not listed in the official regulatory categorization of Common, Uncommon, or Frequency Not Known side effects for Pinaverium bromide.

Q: Does taking Spascolon affect sleep quality?

A: The side effect of somnolence (drowsiness) is listed in the official regulatory profile with a 'Frequency Not Known.' Because drowsiness is a possibility, it could potentially affect overall sleep-wake cycles.

Q: Is Spascolon available generically?

A: The active ingredient in Spascolon is Pinaverium bromide. Whether a generic version is available depends entirely on local regulatory approvals and market availability in the specific region.

How should Spascolon be stored and disposed of?

How to Store and Dispose of Spascolon (Pinaverium Bromide)

Official regulatory guidelines dictate specific environmental controls for the storage and handling of Spascolon.

Storage Requirements

Condition Requirement
Maximum Temperature Do not store above 30°C.
Protection Must be protected from light.
Packaging Keep in the original Alu/PVC blister packs.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

To ensure proper pharmaceutical waste management, the contents and container of expired or unused Spascolon must be disposed of in accordance with local regulation. Patients should follow specific disposal instructions provided by local authorities or healthcare professionals, avoiding disposal in household trash or wastewater unless explicitly permitted.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Spascolon found in:

A-Z Index: